Kiadis Pharma B.V. , a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it will receive an innovation credit of up to a 3 million from AgentschapNL, a division of the Dutch Ministry of Economic Affairs, to support the Phase II clinical development of Kiadis Pharma's lead pipeline product, ATIRa ... (more)
http://www.sys-con.com/node/2715162
http://www.sys-con.com/node/2715162
No comments:
Post a Comment